Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    Family history is not sufficient for assessing inherited disease risk

    09 November 2022

    A new study from the University of Helsinki demonstrates the added value of genetic information in measuring inherited disease risk, alongside the…

    How cryo-EM revealed the secrets of enterovirus replication

    Two researchers at a desk looking at computer screens
    09 November 2022

    How a virus hijacks a host cell to make new virus particles is a key question in the prevention and treatment of virus-caused diseases.

    Sekulić group uses HDX-MS to characterize antibody with potential for breast cancer treatment and diagnostics developed by Kyte group at Oslo University Hospital

    09 November 2022 - Research news

    The study used HDX-MS to map the epitope and paratope of the new high-affinity tumor-specific antibody developed against a variant of HER2. Antibodies…

    Researchers have determined the three-dimensional atomic structure of a protein important for organ functions

    30 October 2022 - Research news

    The so-called NKCC1 protein is found throughout the human body where it has important functions in organs that process fluids or perform…

    Page 24 of 70.

    • Previous
    • 1
    • …
    • 23
    • 24
    • 25
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43